Abu Dhabi launches operations at the regional vaccine distribution center

Abu Dhabi (DOH), organizer of the health care sector in the Emirate of Abu Dhabi, announced the operational launch of the vaccine distribution center in the region in Abu Dhabi, after the first shipments arrived at the facility. It is located in Abu Dhabi and HUB was developed in partnership with prominent international and regional stakeholders, a strategic landmark in the emirate’s vision to promote global health security, ensure fair access to vaccines, and build flexible supply chains throughout the region.

Located in Kezad and run by RAFED, a Purehealth company, HUB was developed in cooperation with the Ministry of Health – Abu Dhabi Investment (Adio), GSK, AD Ports Group, Itihad Cargo and Kezad Group. It is the cornerstone of the ecosystem of life sciences in the United Arab Emirates and is designed to improve the access of the vaccine throughout the region. The axis benefits from the Abu Dhabi strategic website, the infrastructure of the advanced chain, the advanced chain, a graceful organizational environment and the support of innovation. This axis reflects the Abu Dhabi model for cooperation across the sector that unites the government, biofuels, logistics, and innovation under one ecosystem.

Axis activation follows a strategic agreement signed between Doh and GSK through Abu Dhabi Global Healthnursing The week in 2024 to create the capabilities of distribution of regional vaccines in the emirate. I now realized that the facility becomes the first center of vaccine distribution in GSK in the Middle East and the fourth around the world, which increased the consolidation of Abu Dhabi’s role in supporting regional health security and the flexibility of the global supply chain.

The activation of Hub also represents one of the first major operating landmarks under the leadership of Helm – Abu Dhabi’s Life Science Cluster, which was officially launched in April 2025 during the Abu Dhabi Health Week. As the leading platform in the UAE field to advance the investment of life sciences, innovation and global cooperation, Helm combines the government, industry and academic circles to strengthen the Abu Dhabi site as a global partner favorite in precise health, pharmaceutical manufacturing, and vital medicines. HUB integration under HELM explains how Abu Dhabi translates life sciences into operational results that drive regional influence.

He said, Dr. Nora Khamis Al-Ghaitha, Undersecretary of the Ministry of Health-Abu Dhabi: “The operational launch of the Abu Dhabi Regional Center indicates that our willingness to the situation in the region is speed, accuracy and reliability. A reliable partner in global health, where innovation and flexibility translates into time access and the impact of measurable general health. Through this axis, we make vaccines within the reach of border societies and strengthen the leadership of the United Arab Emirates in the prefabricated health care in the future. “

The facility will manage a group of more than 20 vaccines, including those population in children and adults, and support for life -long fortification strategies. The axis can absorb the axis of emerging vaccine technologies and increase regional demand, while maintaining the highest quality standards and global safety.

Boyd Chongfisal, Vice President and Director General, GSK GULF, “The launch of our vaccine distribution center in Abu Dhabi represents a joint commitment to health security, innovation and access. Through our strategic partnership with DOH and local stakeholders, we combine scientific excellence with the operational force to ensure timely connection and clarify them with ABSAIN. The results affecting the life sciences sector on a regional and global scale.

RAFED, the facility operator, has published the cold and smart distribution techniques that maintain the safety of the vaccine and ensure a comprehensive vision during the logistical process. The axis has been fully combined with the pharmacy network of Al -Ittihad, which connects Abu Dhabi to more than 100 international destinations and provides sensitive shipping services for time controlled by the temperature designed for pharmaceutical products.

“As a righteous health a companyRAFED is obliged to provide excellence in the field of health care through global pharmaceutical logistical services. The launch of this regional vaccine distribution center is a tangible expression of our strategy to enhance health systems, improve access, and build flexibility across borders. By publishing advanced cold distribution technologies and smart distribution, we can see in actual and end time. we She still focuses on Government and health partners support with confidence and reliability to achieve better health results for communities from Abu Dhabi across the Middle East, Africa and South Asia. “

The facility is expected to distribute millions of doses annually, leading to the shortcomings of delivery tables throughout the region and improving the safety of the vaccine supply.

“The participation of the Federation in this initiative reflects our continued investment in logistical healthcare services. Our network and specialized pharmacy products play a decisive role in transferring global vaccines sensitive to the temperature and reliable.